Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 21975581)

1.

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease.

Burgunder JM, Guttman M, Perlman S, Goodman N, van Kammen DP, Goodman L.

Version 2. PLoS Curr. 2011 Aug 30 [revised 2011 Oct 11];3:RRN1260.

2.

Effect of tetrabenazine on motor function in patients with huntington disease.

Ferrara JM, Mostile G, Hunter C, Adam OR, Jankovic J.

Neurol Ther. 2012 Sep 29;1(1):5. doi: 10.1007/s40120-012-0005-7. eCollection 2012 Dec.

3.

Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease.

Kegelmeyer DA, Kloos AD, Fritz NE, Fiumedora MM, White SE, Kostyk SK.

J Neurol Sci. 2014 Dec 15;347(1-2):219-23. doi: 10.1016/j.jns.2014.09.053. Epub 2014 Oct 7.

4.

Cell Therapy Strategies vs. Paracrine Effect in Huntington's Disease.

Im W, Kim M.

J Mov Disord. 2014 Apr;7(1):1-6. doi: 10.14802/jmd.14001. Epub 2014 Apr 30. Review.

5.

[Protracted sleep therapy of infectious chorea].

HIMMELFARB SG.

Vopr Pediatrii. 1950;18(4):3-6. Undetermined Language. No abstract available.

PMID:
24538295
6.

An experimental model for Huntington's chorea?

Zeef DH, Jahanshahi A, Vlamings R, Casaca-Carreira J, Santegoeds RG, Janssen ML, Oosterloo M, Temel Y.

Behav Brain Res. 2014 Apr 1;262:31-4. doi: 10.1016/j.bbr.2013.12.036. Epub 2014 Jan 8.

PMID:
24412685
7.

Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases.

Shen V, Clarence-Smith K, Hunter C, Jankovic J.

Tremor Other Hyperkinet Mov (N Y). 2013 Oct 22;3. pii: tre-03-191-4337-1. eCollection 2013.

8.

Pharmacological treatment of chorea in Huntington's disease-good clinical practice versus evidence-based guideline.

Reilmann R.

Mov Disord. 2013 Jul;28(8):1030-3. doi: 10.1002/mds.25500. Epub 2013 May 14. Review.

9.

Treatment of huntington disease.

Videnovic A.

Curr Treat Options Neurol. 2013 Aug;15(4):424-38. doi: 10.1007/s11940-013-0219-8.

10.

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology.

Armstrong MJ, Miyasaki JM; American Academy of Neurology.

Neurology. 2012 Aug 7;79(6):597-603. doi: 10.1212/WNL.0b013e318263c443. Epub 2012 Jul 18.

11.

Comprehensive treatment of Huntington disease and other choreic disorders.

Singer C.

Cleve Clin J Med. 2012 Jul;79 Suppl 2:S30-4. doi: 10.3949/ccjm.79.s2a.06. Review.

12.

Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

Chen JJ, Ondo WG, Dashtipour K, Swope DM.

Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28. Review.

PMID:
22749259
13.

[Methodological approach to inter "guideline" variability in the management of bipolar disorders].

Samalin L, Llorca PM.

Encephale. 2012 Apr;38(2):126-32. doi: 10.1016/j.encep.2011.07.004. Epub 2011 Aug 31. Review. French.

PMID:
22516270
14.

Therapeutics in Huntington's Disease.

Killoran A, Biglan KM.

Curr Treat Options Neurol. 2012 Feb 8. [Epub ahead of print]

PMID:
22314929
15.

An evidence-based approach in the treatment of Huntington's disease.

Mestre TA, Ferreira JJ.

Parkinsonism Relat Disord. 2012 May;18(4):316-20. doi: 10.1016/j.parkreldis.2011.10.021. Epub 2011 Dec 16. Review.

PMID:
22177624
16.

Tetrabenazine: for chorea associated with Huntington's disease.

Scott LJ.

CNS Drugs. 2011 Dec 1;25(12):1073-85. doi: 10.2165/11208330-000000000-00000.

PMID:
22133328
17.

Quadriparesis and dysarthria due to tetrabenazine therapy in a child with rheumatic chorea.

Zaki SA, Lad V, Shanbag P.

Indian J Pharmacol. 2011 Sep;43(5):601-2. doi: 10.4103/0253-7613.84982.

18.

Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.

Jankovic J, Clarence-Smith K.

Expert Rev Neurother. 2011 Nov;11(11):1509-23. doi: 10.1586/ern.11.149. Review.

PMID:
22014129
19.

Pharmacologic approaches to the treatment of Huntington's disease.

Venuto CS, McGarry A, Ma Q, Kieburtz K.

Mov Disord. 2012 Jan;27(1):31-41. doi: 10.1002/mds.23953. Epub 2011 Oct 13. Review.

PMID:
21997232
20.

An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease.

Groves M, van Duijn E, Anderson K, Craufurd D, Edmondson MC, Goodman N, van Kammen DP, Goodman L.

PLoS Curr. 2011 Aug 30;3:RRN1259.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk